一个连接保险、药企和患者的平台企业向港股市场发起冲击。 日前,国内医疗健康服务平台上海镁信健康科技集团(下称“镁信”)在高盛(亚洲)、中金公司及汇丰银行的联席保荐下向港交所交表。 镁信成立于2017年8月,由上药云健康分拆而来,采用“互联网+医药险”模式,链接药企、险企、患者三方形成闭环。 成立以来,镁信累计完成7轮融资,C+轮融资后估值达116.78亿元;其中,2021年的完成B+轮与C轮融资,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.